The authors of this paper created a list of therapies with anti-EBV effects.
Repurposing Licensed Drugs with Activity Against Epstein-Barr Virus for Treatment of Multiple Sclerosis: A Systematic Approach
pubmed.ncbi.nlm.nih.gov/39792343/
#ebv #ms #multiplesclerosis #ebvcausesmsn#art4ms
Repurposing Licensed Drugs with Activity Against Epstein-Barr Virus for Treatment of Multiple Sclerosis: A Systematic Approach
pubmed.ncbi.nlm.nih.gov/39792343/
#ebv #ms #multiplesclerosis #ebvcausesmsn#art4ms
Repurposing Licensed Drugs with Activity Against Epstein-Barr Virus for Treatment of Multiple Sclerosis: A Systematic Approach - PubMed
Scientific and lived experience expert panel review of anti-EBV therapies selected four candidates with evidence for efficacy against EBV and acceptable safety and tolerability for potential use in phase III clinical trials for MS.
pubmed.ncbi.nlm.nih.gov
January 23, 2026 at 6:33 PM
The authors of this paper created a list of therapies with anti-EBV effects.
Repurposing Licensed Drugs with Activity Against Epstein-Barr Virus for Treatment of Multiple Sclerosis: A Systematic Approach
pubmed.ncbi.nlm.nih.gov/39792343/
#ebv #ms #multiplesclerosis #ebvcausesmsn#art4ms
Repurposing Licensed Drugs with Activity Against Epstein-Barr Virus for Treatment of Multiple Sclerosis: A Systematic Approach
pubmed.ncbi.nlm.nih.gov/39792343/
#ebv #ms #multiplesclerosis #ebvcausesmsn#art4ms